Pradaxa Injection

Name: Pradaxa Injection
Brand: SIDMEX INOVIA PRIVATE LIMITED
Price: 400.0 INR
Availability: InStock

400.0 INR/Pack

Get a Price/Quote

Product Details:

Click to view more
Share Your Product:

Request To Call Back Send Inquiry

Pradaxa Injection Price And Quantity

Minimum Order Quantity 497 Pack
Price 400.0 INR/Pack

Pradaxa Injection Trade Information

Payment Terms Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
Supply Ability 10000 Pack Per Week
Delivery Time 4 Days
Sample Available No
Sample Policy If order is confirmed we will reimburse the sample cost
Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
Main Domestic Market All India

Product Description

1. Product Description

Pradaxa Injection contains Dabigatran etexilate, a direct thrombin inhibitor that prevents the formation of blood clots by inhibiting thrombin, a key enzyme in the blood clotting process. It is used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).

2. Product Highlights

Brand Name: Pradaxa
Strength: 50 mg/2 mL
Form: Injection (IV or subcutaneous)
Packaging: Typically 2 mL ampoules
Therapeutic Category: Anticoagulant / Direct Thrombin Inhibitor
Usage: Prescription-only; for use in hospital or clinical settings
Storage: Store below 25C, protect from light, do not freeze

3. Therapeutic Uses

Atrial Fibrillation For stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation
DVT and PE For the treatment and prevention of deep vein thrombosis and pulmonary embolism
Post-Surgical Prophylaxis Prevention of DVT and PE after hip or knee replacement surgery

Rapid and Reliable Anticoagulation

Pradaxa Injection provides fast-acting anticoagulant effects, making it a trusted choice for healthcare professionals managing acute clot-related conditions. Its precision formulation ensures prompt and dependable therapeutic outcomes, especially in time-sensitive medical scenarios.

Strict Safety and Storage Guidelines

This clear, sterile liquid is designed with safety in mind. It should be stored below 25C and protected from light. Patients should avoid using Pradaxa during active bleeding and consult healthcare providers before beginning therapy, particularly those with severe kidney complications.

FAQs of Pradaxa Injection:

Q: How is Pradaxa Injection administered and by whom?

A: Pradaxa Injection is administered as a liquid via injection, typically by trained healthcare professionals in a clinical setting, ensuring precise dosage and monitoring.

Q: What are the main benefits of using Pradaxa Injection over other anticoagulants?

A: Pradaxa Injection provides a rapid onset of action and reliable efficacy, enabling quick prevention or management of blood clots. Its clear, sterile formulation minimizes risk of contamination.

Q: When should Pradaxa Injection be avoided?

A: Pradaxa Injection should not be used during active bleeding episodes or by individuals with severe kidney issues. Always consult a doctor before starting treatment.

Q: Where should Pradaxa Injection be stored to maintain its effectiveness?

A: Store Pradaxa Injection below 25C, protected from light, and keep it out of reach of children to preserve its efficacy and prevent accidental misuse.

Q: What is the composition of Pradaxa Injection?

A: Pradaxa Injection contains Dabigatran Etexilate Mesylate as its active ingredient, along with stabilizing agents that maintain the solutions integrity and potency.

Q: What precautions need to be followed before using Pradaxa Injection?

A: Before using Pradaxa Injection, consult a healthcare provider, especially if you have renal concerns or bleeding history. Do not self-administer and strictly adhere to professional guidance.